Pradeep Chakravarty joins Alembic Pharma as Head - Global Quality

Published On 2023-12-05 06:57 GMT   |   Update On 2023-12-08 10:33 GMT

Vadodara: Alembic Pharma has announced that Pradeep Chakravarty has joined the Company w.e.f. 4th December, 2023, as Head - Global Quality (Senior Management Personnel of the Company).Pradeep Chakravarty has vast experience of more than 29 years in the field of Corporate Quality Assurance, Regulatory Affairs and Pharmacovigilance. He has done M. Tech (Industrial Engineering) from...

Login or Register to read the full article

Vadodara: Alembic Pharma has announced that Pradeep Chakravarty has joined the Company w.e.f. 4th December, 2023, as Head - Global Quality (Senior Management Personnel of the Company).

Pradeep Chakravarty has vast experience of more than 29 years in the field of Corporate Quality Assurance, Regulatory Affairs and Pharmacovigilance. He has done M. Tech (Industrial Engineering) from Calicut University and B.E (Mechanical Engineering) from Andhra University. Prior to joining the Company, he was working with Lupin Limited for more than 11 years. He had also worked for Claris Lifesciences Limited, Nefron Dialysis Services and Core Healthcare Limited.

Read also: Glaucoma drug: USFDA nod to Alembic Pharma Brimonidine Tartrate Ophthalmic Solution

Headquartered in Vadodara, Gujarat, Alembic Pharmaceuticals Limited is involved in manufacturing and marketing India Formulations, International Generics, and Active Pharmaceutical Ingredients with vertical integration capabilities. The company was founded in 1907. Alembic's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the USFDA.

Read also: 6 medicines of Alembic Pharma received USFDA nod during Q2FY24

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News